Pre-vaccine COVID-19: US study reveals hospitalization rate of 5.7% and fatality rate of 1.7%

FHS
May 17, 2024
5:08 am

Study estimates COVID-19 hospitalization and mortality rates in the US during the pre-vaccination period, revealing significant age and racial disparities in outcomes.

Atossa Therapeutics progresses Phase II preventative breast cancer therapy – Pharmaceutical Technology

Share this article Atossa Therapeutics’ CEO discussed updates for its breast cancer program. Credit: NDAB Creativity via Shutterstock Atossa Therapeutics estimates a Q3 readout of

January 26, 2024

Early-stage dementia patients may benefit from Tai Chi, but further research is required

Recent systematic review finds inconclusive evidence on Tai Chi’s ability to delay dementia or improve cognitive function in adults with mild cognitive impairment. The study

November 1, 2023

Lifelong low LDL-C levels key to preventing cardiovascular disease

Research shows maintaining low LDL-C levels over time reduces plaque buildup and lowers ASCVD risk by slowing atherosclerosis progression.

July 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.